RICTOR and breast carcinoma: Due to the several pieces of evidence that confirm the role of the PTEN/AKT pathway in various malignancies, including breast cancer, this study aimed to investigate its involvement in CMTs and FMCs by immunohistochemical analysis of PTEN, phospho-AKT (p-AKT), and Rictor expression.